CPO Tjoapack expands its capacity with a new blister packaging line

| By | Investments, Pharmaceutical Packaging
0
170

Tjoapack, a Netherlands-based global contract packaging organisation (CPO), has invested in its blistering capacity, adding a new line that will be equipped with late-stage customisation printing capabilities.

Expected to be operational by the end of Q3 2018, the new line, at the company’s facility in Etten-Leur, Netherlands, will take its total number of blistering lines to eight.

The investment will also expand Tjoapack’s current postponement printing offering, enabling the CPO to offer drop-on-demand digital printing for blisters. Late-stage customisation, or postponement printing, is something that is presenting some interesting benefits for the pharmaceutical supply chain. The process of only making packaging market-specific once there is a demand could be hugely beneficial in terms of reducing waste from repackaging, overall costs and time to market. The investment will be supported by continued growth of the CPO’s commercial, operational and quality teams.

Founded in 1989, Tjoapack is an independent contract packager of medicines servicing clients across five continents and 42 countries.

The CPO specialises in primary packaging for solid dosage forms, secondary packaging and unit dose packaging and now has a total of 19 packaging lines for blisters, wallets and bottles. Using these lines, it packages around 26 million packs of pharmaceutical products per year, which equates to around 1.4 billion tablets.

SOURCE: bio-it world
SHARE
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.